ATMP: how Belgium paves the way in Europe’s annual event on September 26th focuses on the opportunities in the light of ATMP and how Belgium paves the way in Europe.

In recent years Belgium has developed an expertise throughout the entire value chain: from R&D, clinical trials, bioproduction all the way up to logistics.

During this event, you will get inspired by several top speakers and we’ll tackle the following questions:

  • What are the main regulatory challenges and opportunities?
  • What’s the value of digitalization throughout the end to end value chain?
  • How to embrace Belgium’s CDMO expertise?
  • What’s needed to strengthen the regional talent centers with a specific ATMP focus?
  • And how can Belgium further grow as center of excellence in these topnotch ATMP technologies
    and therapies?


  • 13:30 : Welcome & Registration
  • 14:00 : Event
  • Keynote speech
    Anne Kantardjieff, Vice President Manufacturing at bluebird bio
  • Panel debate
    Sébastien Coppe, Life Sciences Director, N-side
    Luca Russo
    , General Manager Cell & Gene Therapy Campus, Catalent Pharma Solutions
    Birk Vanderweeën
    , General Manager Europe, Legend Biotech
    Jade Verrept
    , Cluster Manager, Science Park Antwerp University & Coordinator at.las, Pom Antwerpen
    Hanne Wouters
    , Market Access specialist,
  • Company testimonial videos from AnicellsExothera and UCB
  • Final keynote speech 
    Hugues Malonne, Director General, DG “Pre-authorization”, Federal Agency for Medicines and Healthcare Products (FAMHP)
  • Closing remarks
    Geoffrey Pot, President of the board
  • 16:00 : Networking reception

The event will be moderated by Frédéric Druck, Secretary General & Tineke Van hooland, Deputy Secretary General

Let’s create, connect and communicate about these future therapies on September 26th, at 14h00.

We hope to see you then!

Registration instructions: please click on the orange button and register via the website.